Provided by Tiger Trade Technology Pte. Ltd.

Jazz Pharmaceuticals PLC

250.68
+6.142.51%
Post-market: 250.00-0.6800-0.27%18:11 EDT
Volume:1.22M
Turnover:305.50M
Market Cap:16.27B
PE:17.14
High:252.72
Open:241.39
Low:241.39
Close:244.54
52wk High:266.38
52wk Low:123.88
Shares:64.91M
Float Shares:62.69M
Volume Ratio:0.59
T/O Rate:1.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.63
EPS(LYR):-5.8403
ROE:22.11%
ROA:6.86%
PB:3.39
PE(LYR):-42.92

Loading ...

Apple, Jazz, Moody’s, AEP, 3M Trending With Analysts

TIPRANKS
·
Jul 18

Jazz Pharmaceuticals Initiated at Buy by Canaccord Genuity

Dow Jones
·
Jul 17

Jazz Pharmaceuticals initiated with a Buy at Canaccord

TIPRANKS
·
Jul 17

Gain Therapeutics Names Joanne Taylor Chief Scientific Officer, Promotes Terenzio Ignoni to COO

Reuters
·
Jul 16

Jazz Pharmaceuticals is Maintained at Overweight by Barclays

Dow Jones
·
Jul 14

Jazz Pharmaceuticals Plc : Barclays Raises Target Price to $260 from $253

THOMSON REUTERS
·
Jul 14

Jazz Pharmaceuticals (JAZZ) Receives a Buy from Jefferies

TIPRANKS
·
Jul 13

Biopharma Pricing Power Seen as Key Swing Factor for Q2 Earnings, BofA Says

MT Newswires Live
·
Jul 11

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 10

Jazz Pharmaceuticals Plc : Deutsche Bank Raises Target Price to $270 from $250

THOMSON REUTERS
·
Jul 09

Jazz Pharmaceuticals price target lowered to $254 from $256 at Truist

TIPRANKS
·
Jul 07

Jazz Pharmaceuticals is Maintained at Buy by Truist Securities

Dow Jones
·
Jul 07

Jazz Pharma Director Bruce C. Cozadd Disposes of 6,000 Shares for $1.44 Million

Reuters
·
Jul 07

Jazz Pharmaceuticals Investors Eye Ziihera Launch in GEA as Key Driver, UBS Says

MT Newswires Live
·
Jul 02

Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), BeOne Medicines (ONC) and Zevra Therapeutics (ZVRA)

TIPRANKS
·
Jul 01

Jazz Pharma director Mark Douglas Smith disposes of 1,157 shares worth $266,146.35

Reuters
·
Jun 18

Jazz Pharma, AbCellera ink antibody deal worth up to $876 million

Reuters
·
Jun 17

Jazz Pharmaceuticals, AbCellera Ink $876 Million Cancer Treatment Pact

Dow Jones
·
Jun 17

Jazz Pharmaceuticals, AbCellera collaborate for TCE multispecific antibodies

TIPRANKS
·
Jun 17

Jazz Pharmaceuticals, AbCellera team up on T-cell engaging multispecific antibodies for GI cancers

Reuters
·
Jun 17